SCHEMBL20186659

SCHEMBL20186659

C#CCCC1NCCc2c1n([Si](C)(C)C(C)(C)C)c1ccc(OC)cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 4/20 0.36
▸ CHRM4 P08173 3/20 0.36
▸ DRD2 P14416 3/20 0.36
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ SLC6A4 P31645 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ PSMD14 O00487 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ MAPKAPK2 P49137 3/20 0.32
▸ MAPKAPK5 Q8IW41 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ PTGS1 P23219 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ MAOA P21397 1/20 0.31
▸ MAOB P27338 1/20 0.31
▸ HTR6 P50406 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20186811 0.77 TP53 (0.37) SLC6A4MAOAMAOB
SCHEMBL20186486 0.71 HTR7 (0.64) HTR7CHRM4DRD2MAPTALDH1A1
SCHEMBL11284818 0.63 KDM4E (0.47) KMT2AKDM4EMAPKAPK2MAPKAPK5MEN1
SCHEMBL20186860 0.62 HTR7 (0.59) HTR7CHRM4DRD2MAPTALDH1A1
SCHEMBL6239283 0.60 MAPKAPK2 (0.58) DRD2MAPTSLC6A4MAPKAPK2MAPKAPK5
SCHEMBL8035821 0.59 KMT2A (0.48) MAPTALDH1A1HTR2BKMT2AKDM4E
SCHEMBL6240818 0.59 MAPKAPK2 (0.56) KMT2AKDM4EMAPKAPK2MAPKAPK5MEN1
SCHEMBL6234161 0.59 MAPKAPK2 (0.59) MAPTMAPKAPK2MAPKAPK5PTGS1PTGS2
Hydrochloric Acid SCHEMBL11629472 0.59 HTR6 (0.41) MAPTALDH1A1HTR2BKMT2AKDM4E
SCHEMBL14043228 0.59 HTR7 (0.71) HTR7CHRM4DRD2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3288921-B1 POLYCYCLIC INDOLINE AND INDOLENINE COMPOUNDS UNIV COLORADO REGENTS (US) 2022-06-15 — — EP disclosed
US-10253024-B2 Polycyclic indoline and indolenine compounds THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2019-04-09 — — US disclosed
US-20180148442-A1 Polycyclic Indoline and Indolenine Compounds THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2018-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253024-B2 Polycyclic indoline and indolenine compounds IDO1, IDO2, INMT HTR7 125/4885CHRM4 2641/4885DRD2 90/4885
US-20180148442-A1 Polycyclic Indoline and Indolenine Compounds IDO1, IDO2, INMT HTR7 125/4885CHRM4 2641/4885DRD2 90/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback